Focus and Scope

The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), a Federation gathering the major national internal medicine societies in Europe.

The journal wants to promote the practice of Internal Medicine in Europe. Its aim is to provide a forum to internal medicine doctors. EJCRIM welcomes papers describing unusual or complex cases and case series that an internist may encounter in everyday practice. Case series are also welcomed as long as they demonstrate the appropriateness of a therapeutical approach or unusual manifestation of a disease.

The journal would also consider brief reasoned reports of issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to scientific meetings of European Societies of Internal Medicine.

The Journal is peer-reviewed with single-blind review. The educational value of case reports is one of the scopes of the Journal.

EJCRIM is freely accessible to all and welcomes submissions from doctors everywhere.

The policy and scope of the journal are outlined in an Editorial of the Editor in Chief John Kellett, MD, and quoted herebelow.

"Modern medicine began in the last half of the nineteenth century when doctors started practising the scientific method at the bedside. However, in his presidential address to the Association of American Physicians in 1979 James Wyngaarden postulated that the clinical scientist was an endangered species[1]. Several reasons for this have been suggested, including "the seductive incomes that now derive from procedure-based specialty medicine". Others have suggested that it is simply because the things left to be discovered at bedside have become exhausted, and that all the big medical advances will now be made by high-powered institutions. This may not, however, be the case. Some of the major advances in medicine, such as the role of Helicobacter pylori in peptic ulcer disease, are still made by bedside clinicians. Furthermore, how are "high-powered" institutions going to do any medical research if there are no more doctors interested in research?

One very simple reason why fewer doctors are interested in clinical research is that it is difficult to get started. (...). For the last twenty years or so this has become more difficult to do. Since case reports do not increase a journal's impact factor most journals are now reluctant to publish them. (...)

Happily things have moved on, and the paradigm of medical publishing is rapidly changing from expensive paper publications with limited capacity, to cheap electronic publications of unlimited capacity the costs of which most authors will find affordable. In this new world it is becoming increasingly clear that open access papers on the internet are much more likely to be cited and read. European Federation of Internal Medicine has, therefore, launching an electronic open access journal called the European Journal of Case Reports in Internal Medicine.

This journal is a sister publication to European Journal of Internal Medicine and provides a forum for internal medicine doctors to report interesting cases, or a series or cluster of cases. All papers submitted to the journal will be peer reviewed. (...)

Potential authors should consider the following caveats before submitting a paper to the journal:

  1. Are they reporting something likely to be of interest to most of their colleagues?
  2. Have they got some photographs, x-rays, CT scans of other material that illustrates their findings?
  3. Is there anything new that is not easily already available on the internet?
  4. Is their report to easy to read, and have they been a brief as possible?
  5. Have you read the journal’s Instructions to Authors?"

References

  1. Wyngaarden, J.B. The clinical investigator as an endangered species. N Engl J Med 1979; 301: 1254–1259

Peer Review Process

The Journal is peer-reviewed with single-blind review.

Open Access Policy

EJCRIM is an open access journal, which means that all published articles are made freely available online to everyone. The costs of publication are covered by a small publication charge, which is payable by authors (or their grant funding body or institution) whose articles are accepted for publication.

Open Access Licence Terms

*Except for the author, who retains the right to make derivative use for scholarly purposes.

See also http://creativecommons.org/licenses/by-nc-nd/4.0/

Publication Ethics and Malpractice Statement

Section A: Publication and authorship

  1. All submitted papers are subject to peer-review by international reviewers that are experts in the area of the particular paper.
  2. The factors that are taken into account in review are relevance, soundness, significance, originality, readability and language.
  3. The possible decisions include: accept, revision required, resubmit for review or decline.
  4. If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised submission will be accepted.
  5. Rejected articles will not be re-reviewed.
  6. The paper acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.
  7. Double Publication is sanctioned with immediate rejection.
  8. EJCRIM will screen submitted content for originality before publication. Authors will be contacted if needed following the screening process.

Section B: Authors' responsibilities

  1. Authors must certify that their manuscripts are their original work.
  2. Authors must certify that the manuscript has not previously been published elsewhere.
  3. Authors must certify that the manuscript is not currently being considered for publication elsewhere.
  4. Authors are expected to be aware of, and comply with, best practice in publication ethics specifically with regard to authorship (for example avoidance of ghost or guest authorship), dual submission, plagiarism, manipulation of figures, competing interests and compliance with policies on research ethics.
  5. Authors are obliged to provide retractions or corrections of mistakes.
  6. All Authors mentioned in the paper must have significantly contributed to the research. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
  7. All authors must be inserted in metadata section when submitting an article.
  8. If the article is already in review, authors’ names cannot be changed unless approved by the EIC.
  9. Authors must provide a patients’ consent form if patients' personal data are submitted.
  10. Authors must provide Ethical Committee Approval by an Institutional Review Board (IRB) when patients trials are considered.
  11. Authors must notify the Editors and the Editorial Office of any conflicts of interest.
  12. Authors must identify all sources used in the creation of their manuscript citing the publications that have been influential in determining the nature of the reported work.

Section C: Reviewers' responsibilities

  1. Reviewers should keep all information regarding papers confidential and treat them as privileged information.
  2. Reviews should be conducted objectively, with no personal criticism of the author.
  3. Reviewers should express their views clearly with supporting arguments.
  4. Reviewers should identify relevant published work that has not been cited by the authors.
  5. Reviewers should also call to the Editor in Chief's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
  6. Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Section D: Editors' responsibilities

  1. Editors have complete responsibility and authority to reject/accept an article.
  2. Editors are responsible for the overall content quality of the publication.
  3. Editors should guarantee the quality of the papers and the integrity of the academic record.
  4. Editors should publish errata pages or make corrections when needed.
  5. Editors must obtain disclosure of conflicts of interests including research funding societies.
  6. Editors should base their decisions solely one the papers' importance, originality, clarity and relevance to publication's scope.
  7. Editors should not reverse their decisions nor overturn the ones of previous editors without serious reason.
  8. Editors should preserve the anonymity of reviewers.
  9. Editors should ensure that all research material they publish conforms to internationally accepted ethical guidelines.
  10. Editors should act if they suspect misconduct, whether a paper is published or unpublished, and make all reasonable attempts to persist in obtaining a resolution to the problem.
  11. Editors should not reject papers based on suspicions, they should have proof of misconduct.
  12. Editors should not allow any conflicts of interest between staff, authors, reviewers and board members.
  13. Authors conflicts of interests as disclosed by the authors are published.

Journal Policies

The complete Journal Policies are available HERE

Journal Archiving and Indexing

This journal utilizes the CNR-SOLAR system to permanently archive the journal for purposes of preservation, reservation and research.

The Journal is also indexed on Google Scholar and DOAJ. We encourage the use of Kudos to maximize the article's visibility.

Journal Stats

In 2016 the journal's rejection rate was 44%. Submissions increased by + 45% from the previous year and therefore the rejection rate increased by + 9%.

The manuscripts are submitted from all over the world, especially from Portugal and italy. See the breakdown:

Sponsors